Entera Bio ENTX Cash Flow Statement (2019-2026)

NASDAQ ENTX
$3.28 +0.06 (+1.71%)
As of: Aug 21, 2026 · 11:30 AM EDT
1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Jun2019 Jun2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter)
-3.21M-4.10M-3.78M-3.19M-3.07M-3.04M-2.19M-2.33M-2.38M-2.00M-2.06M-2.44M-3.02M-2.36M-2.62M-2.73M-3.43M-3.14M-3.61M-4.58M
Depreciation and Depletion (Quarter)
0.01M0.01M0.02M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Share-based Compensation (Quarter)
0.63M0.37M0.96M0.70M0.11M0.48M0.52M0.47M0.38M0.32M0.46M0.60M0.93M0.57M0.60M0.51M0.93M0.71M0.67M0.62M
Deferred Taxes (Quarter)
-0.06M-0.05M-0.03M-0.03M0.21M0.02M0.03M0.01M
Cash from Operations (Quarter)
-2.11M-2.51M-4.79M-2.83M-2.87M-2.01M-1.61M-1.56M-1.52M-2.62M-1.86M-1.33M-2.15M-1.47M-1.40M-1.63M-2.50M-1.83M-3.09M-3.46M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF) (Quarter)
0.01M0.01M0.02M0.02M0.02M0.02M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M0.01M
Change in Working Capital
Change in Receivables (Quarter)
0.14M-0.07M0.03M0.01M0.01M0.01M-0.22M-0.03M0.06M0.08M-0.01M
Change in Account Payables (Quarter)
0.04M-0.16M0.03M-0.09M0.30M-0.40M0.13M0.09M0.32M-0.48M-0.02M0.00M0.12M-0.05M0.00M0.25M-0.17M0.23M-0.17M0.30M
Change in Accured Expenses (Quarter)
0.23M1.10M-0.81M-0.58M-0.76M0.58M0.06M0.19M-0.15M-0.66M0.03M0.17M-0.30M0.31M0.89M0.03M-0.08M0.20M-0.00M-0.01M
Other Working Capital Changes (Quarter)
-0.40M-0.20M1.10M-0.40M-0.32M-0.34M0.36M-0.00M-0.24M-0.17M0.32M-0.09M-0.19M-0.03M0.33M-0.08M-0.03M0.01M0.09M-0.05M
Investing Activities
Capital Expenditures (Quarter)
0.01M0.01M0.02M0.02M0.00M0.00M0.01M0.00M0.01M0.00M0.01M0.03M0.04M0.03M0.00M
Cash from Investing Activities (Quarter)
-0.01M-0.01M-0.02M-0.02M-0.06M-0.00M-0.01M-0.00M-0.01M-0.00M-0.01M-0.03M-0.04M-0.03M-0.00M
Financing Activities
Other financing activities (Quarter)
6.61M0.03M0.56M0.01M0.09M0.15M0.02M0.18M0.15M0.13M
Cash from Financing Activities (Quarter)
2.58M0.02M0.01M0.01M6.03M0.03M1.22M0.01M3.22M13.34M-0.05M0.25M0.17M0.13M9.96M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter)
2.46M0.62M3.34M6.18M0.07M
Additional items
Exchange Rate Effect (Quarter)
-0.07M0.00M0.02M
Change in Cash (Quarter)
0.47M-2.50M-4.82M-2.83M-2.93M-2.01M-1.62M-1.55M-1.52M3.41M-1.83M-0.12M-2.14M1.75M11.93M-1.71M-2.29M-1.72M-2.96M6.49M
Free Cash Flow (Quarter)
-2.12M-2.52M-4.82M-2.85M-2.87M-2.01M-1.62M-1.56M-1.52M-2.62M-1.86M-1.33M-2.15M-1.47M-1.41M-1.66M-2.54M-1.86M-3.09M-3.47M
Net Cash Flow (Quarter)
0.47M-2.50M-4.82M-2.83M-2.93M-2.01M-1.62M-1.55M-1.52M3.41M-1.83M-0.12M-2.14M1.75M11.93M-1.71M-2.29M-1.69M-2.96M6.49M